ATE396729T1 - Stabile flüssige zubereitung enthaltend sitafloxacin - Google Patents

Stabile flüssige zubereitung enthaltend sitafloxacin

Info

Publication number
ATE396729T1
ATE396729T1 AT01922003T AT01922003T ATE396729T1 AT E396729 T1 ATE396729 T1 AT E396729T1 AT 01922003 T AT01922003 T AT 01922003T AT 01922003 T AT01922003 T AT 01922003T AT E396729 T1 ATE396729 T1 AT E396729T1
Authority
AT
Austria
Prior art keywords
liquid preparation
preparation containing
stable liquid
sitafloxacin
containing sitafloxacin
Prior art date
Application number
AT01922003T
Other languages
English (en)
Inventor
Masanori Araki
Hiroaki Nakagami
Azusa Matsukawa
Original Assignee
Daiichi Sankyo Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daiichi Sankyo Co Ltd filed Critical Daiichi Sankyo Co Ltd
Application granted granted Critical
Publication of ATE396729T1 publication Critical patent/ATE396729T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Inorganic Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
AT01922003T 2000-04-24 2001-04-23 Stabile flüssige zubereitung enthaltend sitafloxacin ATE396729T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2000127622 2000-04-24
JP2000149812 2000-05-17

Publications (1)

Publication Number Publication Date
ATE396729T1 true ATE396729T1 (de) 2008-06-15

Family

ID=26590975

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01922003T ATE396729T1 (de) 2000-04-24 2001-04-23 Stabile flüssige zubereitung enthaltend sitafloxacin

Country Status (20)

Country Link
US (1) US7304075B2 (de)
EP (1) EP1277471B1 (de)
JP (1) JP5027975B2 (de)
KR (1) KR100858228B1 (de)
CN (1) CN1326524C (de)
AR (1) AR028028A1 (de)
AT (1) ATE396729T1 (de)
AU (1) AU2001248833A1 (de)
BR (1) BR0110290A (de)
CA (1) CA2406849C (de)
DE (1) DE60134221D1 (de)
DK (1) DK1277471T3 (de)
ES (1) ES2305065T3 (de)
HK (1) HK1050326A1 (de)
MX (1) MXPA02010497A (de)
NO (1) NO323810B1 (de)
PT (1) PT1277471E (de)
RU (1) RU2295342C2 (de)
TW (1) TWI280131B (de)
WO (1) WO2001080858A1 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1525884B1 (de) 2002-07-31 2011-10-12 Senju Pharmaceutical Co., Ltd. Wässrige, flüssigkeitszubereitungen und lichtstabilisierte wässrige flüssigkeitszubereitungen
US8877168B1 (en) 2002-07-31 2014-11-04 Senju Pharmaceuticals Co., Ltd. Aqueous liquid preparations and light-stabilized aqueous liquid preparations
JP2006151808A (ja) * 2002-12-24 2006-06-15 Dai Ichi Seiyaku Co Ltd 抗菌性水性製剤
US20100249413A1 (en) 2006-08-25 2010-09-30 Makoto Murai Stabilized pharmaceutical composition
JP5258331B2 (ja) * 2008-03-03 2013-08-07 ロート製薬株式会社 光安定性が改善されたニューキノロン系抗菌剤含有医薬組成物
WO2010146478A1 (en) * 2009-05-08 2010-12-23 Ranbaxy Laboratories Limited Parenteral composition comprising a fluoroquinolone compound and a nitroimidazole compound
CN101690712B (zh) * 2009-08-25 2011-06-15 武汉武药科技有限公司 一种西他沙星滴眼剂及其制备方法
CN103087042B (zh) * 2012-03-09 2015-02-18 南京优科生物医药有限公司 西他沙星的盐及制药用途
CN110917130A (zh) * 2012-06-27 2020-03-27 武田药品工业株式会社 用盐稳定的胺和有机酸的液体制剂
US20140274997A1 (en) 2013-03-15 2014-09-18 Cubist Pharmaceuticals, Inc. Cephalosporin pharmaceutical compositions
US9872906B2 (en) 2013-03-15 2018-01-23 Merck Sharp & Dohme Corp. Ceftolozane antibiotic compositions
US20140274989A1 (en) 2013-03-15 2014-09-18 Cubist Pharmaceuticals, Inc. Manufacturing beta-lactam combination products
ES2800603T3 (es) 2013-09-09 2021-01-04 Merck Sharp & Dohme Tratamiento de infecciones con ceftolozano/tazobactam en sujetos con insuficiencia renal
US8906898B1 (en) 2013-09-27 2014-12-09 Calixa Therapeutics, Inc. Solid forms of ceftolozane
CN103622973B (zh) * 2013-12-02 2016-05-11 广东恒诚制药有限公司 一种复方醋酸曲安奈德溶液的制备方法
AT524927A1 (de) * 2021-04-07 2022-10-15 Engel Austria Gmbh Plastifiziereinheit für eine Formgebungsmaschine und Verfahren zum Betreiben einer solchen

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3537761A1 (de) * 1985-10-24 1987-04-30 Bayer Ag Infusionsloesungen der 1-cyclopropyl-6-fluor-1,4-dihydro-4-oxo-7- (1-piperazinyl)-chinolin-3-carbonsaeure
MY105136A (en) * 1988-04-27 1994-08-30 Daiichi Seiyaku Co Optically active pyridonecarboxylic acid derivatives.
RU2044544C1 (ru) 1989-04-28 1995-09-27 Дайити Фармасьютикал Ко., Лтд Композиция против вируса иммунодефицита человека
EP0470252A4 (en) 1989-04-28 1992-12-02 Daiichi Pharmaceutical Co., Ltd. Anti-hiv drug

Also Published As

Publication number Publication date
US20030139436A1 (en) 2003-07-24
MXPA02010497A (es) 2003-05-14
KR20020089523A (ko) 2002-11-29
NO20025081L (no) 2002-12-23
DK1277471T3 (da) 2008-08-11
JP5027975B2 (ja) 2012-09-19
HK1050326A1 (en) 2003-06-20
EP1277471A4 (de) 2006-04-12
WO2001080858A1 (fr) 2001-11-01
CN1326524C (zh) 2007-07-18
AU2001248833A1 (en) 2001-11-07
CA2406849C (en) 2007-10-23
ES2305065T3 (es) 2008-11-01
RU2295342C2 (ru) 2007-03-20
CA2406849A1 (en) 2002-10-21
DE60134221D1 (de) 2008-07-10
RU2002128631A (ru) 2004-03-27
EP1277471B1 (de) 2008-05-28
CN1438888A (zh) 2003-08-27
BR0110290A (pt) 2003-02-18
KR100858228B1 (ko) 2008-09-12
AR028028A1 (es) 2003-04-23
TWI280131B (en) 2007-05-01
NO323810B1 (no) 2007-07-09
EP1277471A1 (de) 2003-01-22
PT1277471E (pt) 2008-08-26
NO20025081D0 (no) 2002-10-22
US7304075B2 (en) 2007-12-04

Similar Documents

Publication Publication Date Title
DE60109466D1 (de) Flüssigkristallmischung
DE60217485D1 (de) Stabile flüssige pestizidzusammensetzungen
DE60129705D1 (de) Monoalkylglycerinäther stabile zusammensetzungen
DE60008533D1 (de) Stabile magnetorheologische flüssigkeiten
DE60133540D1 (de) Magnetorheologische flüssigkeit
DE60117117D1 (de) Flüssigkeitsbehälter
DE60025198D1 (de) Stabile biozidale zusammensetzung
DK1370367T3 (da) Væskeforstöver
IS6709A (is) Fljótandi samsetningar metformíns
DE60210429D1 (de) Stabile elektrolumineszenzvorrichtungen
DE50106762D1 (de) Ionische Flüssigkeiten
DE60135213D1 (de) Schmelzgeblasener vliesstoff
DE50101916D1 (de) Flüssige formulierungen
DE60125805D1 (de) Flüssige brotverbesserungsmittel
DE60134221D1 (de) Stabile flüssige zubereitung enthaltend sitafloxacin
ID30187A (id) Dongkrak jenis pantagraf
DE60126069D1 (de) Flüssigkeitsspender
DE60131992D1 (de) Pfropfcopolymere enthaltende klebstoffe
NO20032144L (no) Stabile flytende suspensjonssammensetninger og fremgangsmåte for fremstilling og anvendelse derav
DE60215601D1 (de) Stabile Zusammensetzung
DE60007044D1 (de) Stabile biozide Zusammensetzungen
DE60107109D1 (de) Flüssigkeitsabgabevorrichtung
DE60010757D1 (de) Laser-oszillatorvorrichtung
DE50109358D1 (de) Flüssigkristall-Anzeige
DE60101015D1 (de) Oszillator

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1277471

Country of ref document: EP

REN Ceased due to non-payment of the annual fee